Terms: = Bone cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Staging
222 results:
1. [Analysis of factors influencing the efficacy and prognosis of surgical treatment for primary malignant pelvic bone tumors].
Liu WF; Hao L; Li ZY; Jin T; Sun Y; Yang YK; Li Y; Yang FJ; Yu F; Zhang Q; Niu XH
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):344-353. PubMed ID: 38644270
[No Abstract] [Full Text] [Related]
2. [
Li B; Ding X; Duan L; Shi J; Tang M; Zhang J; Zhao Z; Wu X; Gao Y
Front Endocrinol (Lausanne); 2024; 15():1326858. PubMed ID: 38449842
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors for distant metastasis of Chondrosarcoma in the middle-aged and elderly people.
Deng GH
Medicine (Baltimore); 2023 Nov; 102(44):e35562. PubMed ID: 37932996
[TBL] [Abstract] [Full Text] [Related]
4. Fibroblast Activation Protein-Targeted PET/CT with
Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.
Ruan D; Zhao L; Cai J; Xu W; Sun L; Li J; Zhang J; Chen X; Chen H
Theranostics; 2023; 13(13):4694-4710. PubMed ID: 37649615
[No Abstract] [Full Text] [Related]
6. Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study.
Hottat NA; Badr DA; Ben Ghanem M; Besse-Hammer T; Lecomte SM; Vansteelandt C; Lecomte SL; Khaled C; De Grove V; Salem Wehbe G; Cannie MM; Jani JC
Eur Radiol; 2024 Jan; 34(1):165-178. PubMed ID: 37555959
[TBL] [Abstract] [Full Text] [Related]
7. [
Yang L; Xu S; Cheng L; Gao C; Cao S; Chang Z; Wang K
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4051-4063. PubMed ID: 37542659
[TBL] [Abstract] [Full Text] [Related]
8.
Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
[TBL] [Abstract] [Full Text] [Related]
9. [
Metser U; Kulanthaivelu R; Salawu A; Razak A; Mak V; Li X; Langer DL; MacCrostie P; Singnurkar A
J Nucl Med; 2023 Sep; 64(9):1371-1377. PubMed ID: 37414444
[TBL] [Abstract] [Full Text] [Related]
10. Targeted Biopsy in Men High Risk for Prostate cancer:
Pepe P; Pennisi M
Clin Genitourin Cancer; 2023 Dec; 21(6):639-642. PubMed ID: 37394379
[TBL] [Abstract] [Full Text] [Related]
11. A quantitative analysis of spectral computed tomography characteristics of osseous metastases.
Cheng CT; Gwini S; Craig G
J Med Imaging Radiat Oncol; 2023 Sep; 67(6):595-601. PubMed ID: 37186505
[TBL] [Abstract] [Full Text] [Related]
12. Head-to-Head Comparison of [
Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
[No Abstract] [Full Text] [Related]
13.
Pepe P; Pepe L; Tamburo M; Marletta G; Savoca F; Pennisi M; Fraggetta F
In Vivo; 2023; 37(3):1318-1322. PubMed ID: 37103095
[TBL] [Abstract] [Full Text] [Related]
14. FAPI-avid nonmalignant PET/CT findings: An expedited systematic review.
Bentestuen M; Al-Obaydi N; Zacho HD
Semin Nucl Med; 2023 Sep; 53(5):694-705. PubMed ID: 36813670
[TBL] [Abstract] [Full Text] [Related]
15. Sinonasal intestinal- and non-intestinal-type adenocarcinoma in China: a retrospective study of 14 cases.
Li G; Shi Y; Liu Q; Zhang H; Xue K; Song X; Gu Y; Sun X; Dai Q; Yu H
Acta Otolaryngol; 2023 Feb; 143(2):185-190. PubMed ID: 36780311
[TBL] [Abstract] [Full Text] [Related]
16. Automated lung cancer assessment on 18F-PET/CT using Retina U-Net and anatomical region segmentation.
Weikert T; Jaeger PF; Yang S; Baumgartner M; Breit HC; Winkel DJ; Sommer G; Stieltjes B; Thaiss W; Bremerich J; Maier-Hein KH; Sauter AW
Eur Radiol; 2023 Jun; 33(6):4270-4279. PubMed ID: 36625882
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic Performance of PET/MRI in Breast cancer: A Systematic Review and Bayesian Bivariate Meta-analysis.
Ruan D; Sun L
Clin Breast Cancer; 2023 Feb; 23(2):108-124. PubMed ID: 36549970
[TBL] [Abstract] [Full Text] [Related]
18. Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Mina R; Musto P; Rota-Scalabrini D; Paris L; Gamberi B; Palmas A; Aquino S; de Fabritiis P; Giuliani N; De Rosa L; Gozzetti A; Cellini C; Bertamini L; Capra A; Oddolo D; Vincelli ID; Ronconi S; Pavone V; Pescosta N; Cea M; Fioritoni F; Ballanti S; Grasso M; Zamagni E; Belotti A; Boccadoro M; Gay F
Lancet Oncol; 2023 Jan; 24(1):64-76. PubMed ID: 36528035
[TBL] [Abstract] [Full Text] [Related]
19. staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement.
Guinot A; Tabone-Eglinger S; Isnardi V; Bahri H; Surdez D; Delattre O; Pierron G; Villemeur M; Lapouble E; Brahmi M; Bouhamama A; Corradini N; Marec-Bérard P
Eur J Cancer; 2023 Jan; 179():56-64. PubMed ID: 36502618
[TBL] [Abstract] [Full Text] [Related]
20. Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial.
Sonneveld P; Chanan-Khan A; Weisel K; Nooka AK; Masszi T; Beksac M; Spicka I; Hungria V; Munder M; Mateos MV; Mark TM; Levin MD; Ahmadi T; Qin X; Garvin Mayo W; Gai X; Carey J; Carson R; Spencer A
J Clin Oncol; 2023 Mar; 41(8):1600-1609. PubMed ID: 36413710
[TBL] [Abstract] [Full Text] [Related]
[Next]